Coronavirus-19: Clinical Trials

2 trials for Coronavirus-19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1

Follow Coronavirus-19: new trials by email Literature Review of Coronavirus-19 trials Research Report on Coronavirus-19

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Combination Therapy to Treat COVID-19 Infection
Ivermectin, Doxycycline Hcl, Zinc - COVID, Covid-19
Phase 1CompletedProgenaBiome312020-12-092024-09-24
A Study of ResCureā„¢ to Treat COVID-19 Infection
ResCureā„¢ - COVID, Covid-19
Phase 1WithdrawnProgenaBiome2020-01-012021-04-08

Narrower conditions

COVID-19 (2)  ·  Coronavirus Infections (2)  ·  Severe Acute Respiratory Syndrome (1)

Broader conditions

Coronaviridae Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)

Interventions

Ascorbic Acid (1)  ·  Cholecalciferol (1)  ·  Doxycycline (1)  ·  Ivermectin (1)  ·  Zinc (1)  ·  Zinc Sulfate (1)

Sponsors

ProgenaBiome (2)

Countries

United States (2)

Top investigators

Sabine Hazan, MD (2)  ·  Thomas Borody, MD (1)

Results publications

PMID 35135310, PMID 39702045